A detailed history of Schechter Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 22,243 shares of AZN stock, worth $1.49 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
22,243
Previous 22,006 1.08%
Holding current value
$1.49 Million
Previous $1.72 Million 0.99%
% of portfolio
0.17%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $18,170 - $20,765
237 Added 1.08%
22,243 $1.73 Million
Q2 2024

Aug 12, 2024

BUY
$66.81 - $80.83 $470,208 - $568,881
7,038 Added 47.02%
22,006 $1.72 Million
Q1 2024

May 06, 2024

BUY
$61.03 - $69.57 $151,781 - $173,020
2,487 Added 19.93%
14,968 $1.01 Million
Q4 2023

Jan 17, 2024

SELL
$61.89 - $69.28 $29,830 - $33,392
-482 Reduced 3.72%
12,481 $840,000
Q3 2023

Nov 06, 2023

SELL
$64.85 - $71.7 $30,674 - $33,914
-473 Reduced 3.52%
12,963 $877,000
Q2 2023

Jul 26, 2023

BUY
$69.91 - $75.81 $29,921 - $32,446
428 Added 3.29%
13,436 $961,000
Q1 2023

Apr 28, 2023

SELL
$63.15 - $71.6 $4,799 - $5,441
-76 Reduced 0.58%
13,008 $902,000
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $77,899 - $101,222
1,437 Added 12.34%
13,084 $887,000
Q3 2022

Nov 04, 2022

SELL
$53.02 - $135.75 $16,489 - $42,218
-311 Reduced 2.6%
11,647 $639,000
Q2 2022

Nov 03, 2022

BUY
$59.26 - $71.14 $708,631 - $850,692
11,958 New
11,958 $790,000
Q1 2022

Nov 18, 2022

SELL
$55.72 - $67.12 $15,935 - $19,196
-286 Reduced 2.46%
11,361 $754,000
Q4 2021

Dec 27, 2022

SELL
$54.02 - $63.83 $155,847 - $184,149
-2,885 Reduced 24.77%
8,762 $510,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.